MOTS-c attenuates airway barrier dysfunction in allergic asthma by inhibiting epithelial apoptosis via Nrf2 pathway.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Animal
Published: 2025-06-04
Authors: Zhang W, Li S, Zhang Y, Wu Y, Chen D, Pang Q, Han S.
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: Wuxi Health Commission; Jiangsu Commission of Health; Jiangsu Provincial Health Commission
Identifiers: DOI: 10.1016/j.intimp.2025.115014 · PMID: 40472776
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗